Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).

ABSTRACT: As a malignant tumor type, nasopharyngeal carcinoma (NPC) is characterized by distinct geographical, ethnic and genetic differences; presenting a major threat to human health in many countries, especially in Southern China. At present, no accurate and effective methods are available for the early diagnosis, efficacious evaluation or prognosis prediction for NPC. As such, a large number of patients have locoregionally advanced NPC at the time of initial diagnosis. Many patients show toxic reactions to overtreatment and have risks of cancer recurrence and distant metastasis owing to insufficient treatment. To solve these clinical problems, high‑throughput '‑omics' technologies are being used to screen and identify specific molecular biomarkers for NPC. Because of the lack of comprehensive de

SUBMITTER: Zhang SQ 

PROVIDER: S-EPMC7910009 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature